Table 3

Overview of EBV antibody status and EBV-specific T-cells in SLE patients and healthy controls

 EBNA1EBV-EA/D
IgGIgAIgMIgGIgAIgM
EBV antibody status
 SLE patients (n=22), %861432736427
 Healthy controls (n=22), %9559995
 EBNA1EBV-EA/D
TotalCD8CD4TotalCD8CD4
EBV-specific (CD69) T-cell status
 SLE patients (n=22), %413227231814
 Healthy controls (n=22), %957791686859
  • EBV, Epstein–Barr virus; EBNA1, EBV nuclear antigen 1; EBV-EA/D, EBV early antigen diffuse; SLE, systemic lupus erythematosus.